This observation underscores the potential of circFOXK2 as a therapeutic target in cancer, highlighting its ability to modulate both full-length and some mutated CCND1 alterations, thus offering a potential avenue for treatment even in the presence of mutation-induced alterations. This evidence concerns the gene CCND1 and cancer.